Mendelian Randomization and Multi-Omics Analysis of Antibody-Mediated Immune Response in Relation to Pancreatic Cancer Risk and Drug Target Identification

Fig2. Causal Effects of Antibodies on PC RiskFig3. Sensitivity Analyses of Four Antibodies with Significant Causal Associations to PC RiskFig4. Differential Expression of Significant Genes in Various DatabasesFig5. Prognostic Model Development and Validation Using Random Forest AlgorithmFig6. Single-Cell Analysis of HK2 and DTNA in Pancreatic CancerFig7. Immunotherapy Response and Expression Patterns of HK2 and DTNAFig8. Forest plot of drug sensitivity analysisSupplementary Material